BioPharma Dive 24 nov 2025 Bayer’s experimental blood-thinner notches trial win in stroke prevention #Asundexian Phase #prevention Asundexian
BioPharma Dive 24 nov 2025 Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer
BioPharma Dive 24 nov 2025 FDA probes effects of Takeda rare disease drug after patient death #FDA probes #Takeda rare
BioPharma Dive 24 nov 2025 Biogen strikes deal with Versant-backed biotech to expand immune portfolio #Dayra Therapeutics #Versant-backed biotech
BioPharma Dive 24 nov 2025 APOE4 and CRISPR are reframing Alzheimer’s Risk #reframing Alzheimer #CRISPR brings
BioPharma Dive 21 nov 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers
BioPharma Dive 21 nov 2025 FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M #quick clarifications #FDA tests
BioPharma Dive 21 nov 2025 GSK, Anaptysbio sue each other over Jemperli revenue #Jemperli revenue #royalty business
BioPharma Dive 21 nov 2025 A brain biotech’s top drug fails against MS #Contineum Therapeutics #Therapeutics dipped
BioPharma Dive 20 nov 2025 Moderna secures $1.5B lifeline as it looks to break even in 2028 #Moderna secures #day event